Viberzi (ALLERGAN USA, INC.)


Welcome to the PulseAid listing for the Viberzi drug offered from ALLERGAN USA, INC.. This mu-Opioid Receptor Agonist [EPC],Opioid mu-Receptor Agonists [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: ALLERGAN USA, INC.
NON-PROPRIETARY NAME: Eluxadoline
SUBSTANCE NAME: ELUXADOLINE
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: mu-Opioid Receptor Agonist [EPC],Opioid mu-Receptor Agonists [MoA]
ROUTE: ORAL
DOSAGE FORM: TABLET, FILM COATED
MARKETING CATEGORY NAME: NDA
START MARKETING DATE: 2015-10-01
END MARKETING DATE: 0000-00-00


Viberzi HUMAN PRESCRIPTION DRUG Details:

Item DescriptionViberzi from ALLERGAN USA, INC.
LABELER NAME: ALLERGAN USA, INC.
DEA SCHEDULE: CIV
ACTIVE STRENGTH: 75(mg/1)
START MARKETING DATE: 2015-10-01
END MARKETING DATE: 0000-00-00
PRODUCT ID: 61874-075_c116624b-c190-4119-ab69-900d12b9795f
PRODUCT NDC: 61874-075
APPLICATION NUMBER: NDA206940

Other ELUXADOLINE Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
ALLERGAN USA, INC.Viberzi